Kyoto Furitsu Medical University Hospital

Kyoto 602-8566

0 studies enrolling now · 5 studies all time

What they study most

B-cell Lymphoma, Chronic Lymphocytic Leukemia, Crohn's Disease, Lymphoma, Mantle-Cell, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Psoriasis, Small Lymphocytic Lymphoma, Waldenstrom Macroglobulinemia

Studies at this site

• Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL) — Running, not enrolling
• A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) — Running, not enrolling
• A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL — Completed
• A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed
• A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3) — Stopped early